Cite
HARVARD Citation
Takahama, T. et al. (2020). Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M–positive non–small cell lung cancer: West Japan Oncology Group 8815L/LPS study. Cancer. 126 (9), pp. 1940-1948. [Online].